Peter Goodfellow is a Senior Science Advisor for Abingworth. Peter was previously the Balfour Professor of Genetics at the University of Cambridge before working for SmithKline Beecham (later GSK) as Head of Research. He has founded several biotechnology companies and has sat on the Boards of Prosensa, deCode, GenSight Biologics, and various medical charities.
Peter holds doctorates from the Universities of Oxford and Bristol. He is also a Fellow of the European Molecular Biology Organisation (EMBO), the Academy of Medical Sciences, and the Royal Society.